CAI Marks Thirty Years Advancing Operational Readiness and Excellence Across Life Sciences and Mission-Critical Industries
13.4.2026 13:57:00 CEST | Business Wire | Press release
From CQV roots to a broader operational readiness model, CAI continues helping organizations navigate rising complexity and operate with confidence and speed in highly regulated environments
Marking 30 years as an industry leader, CAI, a professional services firm composed of engineering, quality and operations experts, is defining what operational readiness means for highly regulated life sciences and mission-critical industries. As the field enters a new era of digital transformation and innovation, the deep technical knowledge, structured methodologies, risk-based frameworks and teams of experts at CAI help clients bridge emerging technologies with practical execution.
“At CAI, our legacy is not simply about longevity,” said CAI CEO Sheena Dempsey. “Our engineers and quality and operations experts consistently deliver solutions that allow clients to operate confidently and effectively. As we move forward into a new decade, we are committed to continuing to evolve and innovate readiness and best practices, whether at a single facility or for global organizations that need to scale across complex manufacturing networks.”
For more than 30 years, CAI has helped define what operational readiness means in highly regulated environments. At a time when few firms specialized in CQV (commissioning, qualification, and validation), CAI established itself as an early leader in this rapidly evolving industry and built on that foundation over time. The results for its clients include:
- Accelerated facility and system readiness to support quicker delivery of medicines and therapies to patients.
- Rigorous CQV to ensure systems meet global compliance standards and stand up to regulatory scrutiny.
- Reduced risk and project delays by identifying and resolving issues early, helping organizations avoid costly rework and keep complex projects on track.
- Scalable operational excellence to enable global organizations to standardize best practices and maintain reliable, compliant operations across complex manufacturing networks.
CAI delivers operational readiness and performance excellence across both Life Sciences and Mission-Critical environments, helping organizations navigate complexity with confidence.
Life Sciences
- Advance operational readiness by delivering integrated commissioning, qualification, and validation (CQV) that ensures facilities, systems, and processes are inspection-ready from day one
- Strengthen operational excellence by optimizing manufacturing and quality systems to improve performance, consistency, and long-term compliance
- Implement structured, risk-based frameworks that enable efficient startup, sustained control, and proactive regulatory readiness
- Guide organizations through critical readiness milestones by aligning people, processes, and technology to accelerate time to market and reliable operations
Mission Critical
- Lead commissioning management, scheduling, and staffing for complex data center developments
- Perform design reviews and integrated systems testing to ensure reliability and performance
- Support digital integration and operational excellence across facilities and systems
- Develop maintenance strategies to sustain uptime and long-term efficiency
“At the heart of our sustained success is our amazing team of experts that continuously support operational readiness and excellence,” Dempsey added. “Through a shared commitment to doing the work right, our employees are empowered to develop solutions, share lessons learned, and continuously raise the bar. That collective expertise is how we deliver consistent results across projects of varying sizes and complexities across the globe.”
CAI Founder Bob Chew said, “Looking back on the past three decades, I’m incredibly proud of how far our company has come and the role our people have played in supporting the safe, efficient delivery of medicines and critical therapies to patients worldwide. Our growth has always been driven by listening to our clients and anticipating what they’ll need next. As we enter our fourth decade, that commitment is unwavering and guides us to help shape the future of life sciences and mission-critical operations.”
ABOUT CAI
CAI is a professional services firm composed of engineering, quality, and operations experts dedicated to accelerating operational readiness and excellence in life sciences and mission-critical environments. With deep roots in CQV (commissioning, qualification, validation), CAI has evolved over the past 30 years alongside the industries it serves, helping organizations bring complex facilities, systems, and technologies online with confidence.
The elite team at CAI combines deep technical expertise with proven processes and modern tools to deliver projects on time and within budget, supporting outcomes that matter in highly regulated environments. Over three decades, CAI has embraced new modalities and guided clients through digital transformation while strengthening operational readiness. As industry demands grow, CAI continues to define the next era of agility, resilience, and operational excellence.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260413035076/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Aarhus Vand Selects Netmore for Smart Meter Network25.8.2026 08:00:00 CEST | Press release
Partnership between Netmore, Aarhus Vand, and Kamstrup supports digitalization of metering network and water conservation across Aarhus Municipality, Denmark Netmore Group, the leading network operator and platform provider for Massive IoT, today announced a collaboration with Aarhus Vand and Kamstrup to support the deployment of approximately 69,000 digitally connected water meters across Aarhus Municipality, Denmark. Powered by Netmore's carrier-grade LoRaWAN® network and Kamstrup's digital water metering technology, the project will provide Aarhus Vand with real-time visibility into water consumption while helping residents better understand and reduce their water usage. Rollout begins in Tranbjerg following a successful pilot involving approximately 1,000 households, where the communication between Kamstrup's digital meters and Aarhus Vand was validated. The full deployment will continue through 2030, covering communities across Aarhus Municipality. The new water meters will elimin
Motorola Solutions fuldfører opkøbet af D-Fend Solutions25.8.2026 08:00:00 CEST | Pressemeddelelse
Beskyttelse af luftrummet for beredskabsmyndigheder og kritisk infrastruktur med differentieret, ikke-kinetisk RF-teknologi til cyberovertagelse Motorola Solutions (NYSE: MSI) har gennemført opkøbet af D-Fend Solutions (D-Fend), der er en førende virksomhed inden for anti-drone-teknologi, for en købspris på 1,5 mia. USD. Handlen giver beredskaber og erhvervsliv adgang til avancerede systemer til bekæmpelse af ubemandede luftfartøjer (C-UAS), der er udviklet til sikkert at neutralisere trusler fra uautoriserede droner. "Sikkerhed på jorden kræver sikkerhed i luften," siger Greg Brown, der er bestyrelsesformand og CEO i Motorola Solutions. "D-Fends gennemprøvede anti-drone-teknologi er et stærkt supplement til vores beredskabsløsninger og giver vores kunder verden over en differentieret beskyttelse af luftrummet." Præcis trusselsbegrænsning I modsætning til traditionelle anti-drone-metoder, der baserer sig på simpel detektion efterfulgt af jamming eller nedskydning, identificerer D-Fends
IFF Report Finds GLP-1 Is Reshaping Food Choices and Eating Behaviors Among Indian Consumers25.8.2026 07:30:00 CEST | Press release
Research highlights emerging opportunities for food and beverage innovation IFF (NYSE: IFF) — a global leader in flavors, fragrances and health and biosciences — released new research examining how GLP-1 use is influencing food behaviors among Indian consumers and what those shifts may mean for the future of food and beverage innovation. The study is the latest in IFF’s GLP-1 global consumer insights following the company’s 2025 GLP-1 Consumer Opportunity Outlook. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824816059/en/ “We are seeing that a change in appetite can lead to a broader change in the relationship people have with food, from how much consumers eat to how they choose, experience and participate in eating occasions,” said Harsch Koshti, regional marketing director, IFF Taste for Greater Asia. “For the food industry, this is a critical opportunity to listen closely to these emerging behaviors and think about h
Tigo Energy and Ingeteam Sign Certificate of Compatibility25.8.2026 06:00:00 CEST | Press release
Successful testing between Tigo MLPE and Ingeteam inverters validates an open ecosystem with proven compatibility for European solar installers. Tigo Energy, Inc. (NASDAQ: TYGO), a leading provider of intelligent solar and energy solutions, today announced a Certificate of Compatibility with European energy technology leader, Ingeteam S.A., documenting which Ingeteam inverters and Tigo Flex MLPE products have passed compatibility testing. The certificate covers certain single-phase and three-phase INGECON® SUN products and members of the Tigo TS4 MLPE product family, when properly designed and installed. Together, these products are designed to deliver high-quality, enhanced value with a system that can generate and manage solar energy more efficiently and provide the features that solar energy customers in the residential, Commercial and Industrial (C&I) and Utility segments demand. Ingeteam, a leading decarbonization and energy transformation company building a sustainable future thr
Celltrion Expands Omlyclo® Portfolio in Europe with Launch of 300 mg Strength25.8.2026 00:40:00 CEST | Press release
Omlyclo® (omalizumab) 300 mg launched in key European markets including Germany, the UK and France, with rollout to expand across Europe by year-endOmlyclo® 300 mg strength available in both pre-filled syringe (PFS) and autoinjector (AI) presentationsMultiple dose strengths and device options broaden treatment flexibility for healthcare professionals Celltrion (KRX: 068270) today announced the launch of the 300 mg strength of Omlyclo® (omalizumab), a treatment for chronic spontaneous urticaria and allergic asthma, in Europe.1 With the addition of the 300 mg strength, Celltrion has expanded its Omlyclo® portfolio to include multiple dose strengths and device presentations for patients, healthcare professionals and healthcare institutions. Following the European launch of Omlyclo® 75 mg and 150 mg late last year, Celltrion began rolling out the 300 mg strength in key markets including Germany, the UK and France in the middle of this year. Celltrion is gradually expanding supply to other
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom